Old API Wind-down Ltd. Stock

Stocks

ARLZQ

CA03852X1006

Pharmaceuticals

OTC Markets Traded
Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for Old API Wind-down Ltd. -.--% -

Valuation: Old API Wind-down Ltd.

Market Cap 87.35K 76.7K 70.59K 65.78K 124K 8.3M 127K 849K 329K 4.08M 328K 321K 14.19M P/E 2016
-2.53x
P/E 2017 -0.75x
Enterprise Value 246M 216M 199M 185M 349M 23.36B 356M 2.39B 925M 11.47B 923M 903M 39.91B EV / Sales 2016
9.18x
EV / Sales 2017 3.22x
Free-Float
100%
Yield 2016 *
-
Yield 2017 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 0
-0.64%+6.67%+53.59%+154.11% 1,063B
+0.00%+5.39%+62.89%+53.44% 611B
-0.23%+6.88%+32.14%+86.34% 444B
-1.20%-0.96%+26.12%+20.22% 324B
-1.74%-0.40%+33.19%+22.86% 285B
-1.25%+0.53%+27.68%+38.89% 283B
+2.99%+4.00%-26.09%-41.06% 219B
-0.22%+2.82%+24.37%+62.75% 195B
-0.29%+0.65%+12.75%+63.45% 156B
Average -0.26%+2.54%+27.41%+51.22% 358.07B
Weighted average by Cap. -0.41%+4.16%+38.12%+75.97%

Financials

2016 2017
Net sales 54.27M 47.65M 43.86M 40.87M 77.08M 5.16B 78.64M 528M 204M 2.53B 204M 199M 8.81B 106M 93.02M 85.62M 79.79M 150M 10.07B 154M 1.03B 399M 4.94B 398M 389M 17.21B
Net income -103M -90.41M -83.22M -77.55M -146M -9.79B -149M -1B -388M -4.81B -387M -378M -16.73B -125M -110M -101M -94.29M -178M -11.9B -181M -1.22B -472M -5.84B -470M -460M -20.34B
Net Debt 209M 184M 169M 158M 298M 19.92B 304M 2.04B 789M 9.78B 787M 770M 34.03B 246M 216M 199M 185M 349M 23.36B 356M 2.39B 925M 11.46B 922M 902M 39.9B
Logo Old API Wind-down Ltd.
Old API Wind-Down Ltd, formerly Aralez Pharmaceuticals Inc., is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company's products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G. Its development products include YOSPRALA and Bilastine. Fibricor (fenofibric acid) is indicated as a complementary therapy along with diet for the treatment of hypertriglyceridemia, and as a complementary therapy along with diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), triglycerides (TG) and apolipoprotein B (Apo B). Fibricor is also used to increase high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with hypercholesterolemia or mixed dyslipidemia. Cambia (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug (NSAID).
Employees
-
  1. Stock Market
  2. Stocks
  3. ARLZQ Stock